Picture of Adiuvo Investments SA logo

ADV Adiuvo Investments SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
FinancialsHighly SpeculativeMicro CapSucker Stock

Momentum

Relative Strength (%)
1m+0.3%
3m-6.25%
6m+1.13%
1yr+9.32%
Volume Change (%)
10d/3m-92.19%
Price vs... (%)
52w High-47.54%
50d MA+0.66%
200d MA+4.75%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Margin-2411.62%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202331st Dec 2024
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2023 / 2024

Blurred out image of Adiuvo Investments SA EPS forecast chart

Profile Summary

Adiuvo Investments SA is a Poland-based company engaged in the financial industry. The Company focuses on the selection, development, financing and commercialization of biomedical projects on the international market. By providing intellectual property protection, technology validation in clinical trials and obtaining certificates allowing products to market, Adiuvo Investments SA is able to commercialize projects in diverse business model and internationally. The Company is looking for and invests in projects in the segments of the nutraceutical, medical devices and the digital health. Its business portfolio encompasses Airway Medix, Algae Labs, Carocelle, Cambridge Chocolate Technology, Endomedical, Esthechoc, Glia, Joint Polish Investment Fund, Marmar Investment, Nanoxide and Peptaderm.

Directors

Last Annual
December 31st, 2022
Last Interim
September 30th, 2023
Incorporated
August 24th, 2012
Public Since
May 27th, 2015
No. of Employees
8
Sector
Investment Banking & Investment Services
Industry
Financials
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
13,174,346

ADV Share Price Performance

Upcoming Events for ADV

Similar to ADV

Picture of AerFinance logo

AerFinance

pl flag iconWarsaw Stock Exchange

Picture of Altus SA logo

Altus SA

pl flag iconWarsaw Stock Exchange

Picture of Capital Partners SA logo

Capital Partners SA

pl flag iconWarsaw Stock Exchange

FAQ